4min chapter

The Carlat Psychiatry Podcast cover image

Cobenfy: A New Antipsychotic

The Carlat Psychiatry Podcast

CHAPTER

Intro

This chapter explores the FDA's recent approval of Cabenphi, an antipsychotic with a unique mechanism that moves beyond traditional dopamine antagonists. It also recounts personal experiences during a tumultuous conference impacted by Hurricane Helene, while delving into the scientific background of its key component, xanomaline.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode